Showing posts with label AI. Show all posts
Showing posts with label AI. Show all posts

Friday, 8 September 2023

Exploring the World of Generative Chemistry with Reinforcement Learning: Significance and Limitations

Introduction:

Generative chemistry, powered by cutting-edge technologies like reinforcement learning, is revolutionizing the field of drug discovery and materials science. In this blog, we'll delve into what generative chemistry is, how it harnesses reinforcement learning, its significance, and the challenges it faces.

Understanding Generative Chemistry:

Generative chemistry is an interdisciplinary field that combines chemistry, computer science, and artificial intelligence (AI) to design and discover new molecules, materials, and chemical reactions. It leverages algorithms and machine learning techniques to predict and generate novel chemical structures, properties, and reactions, ultimately accelerating the drug discovery process and materials development.

Reinforcement Learning in Generative Chemistry:

Reinforcement learning (RL), a subset of AI, plays a pivotal role in generative chemistry. RL algorithms learn to make sequences of decisions in an environment to maximize a cumulative reward. In generative chemistry, the "environment" is a vast chemical space, and the "agent" is an algorithm that explores this space by creating and evaluating molecules or materials.

Significance of Generative Chemistry with RL:

1. Accelerated Drug Discovery:
   - Traditional drug discovery is time-consuming and costly. Generative chemistry with RL can significantly expedite the process by predicting novel drug candidates and their properties.

2. Exploration of Chemical Space:
   - Generative chemistry allows scientists to explore uncharted regions of the chemical space, leading to the discovery of materials with unique properties.

3. Customized Materials:
   - Researchers can design materials with specific characteristics, such as improved conductivity, strength, or catalytic activity, tailored to meet various industrial and scientific needs.

4. Reduced Costs:
   - By minimizing the need for extensive experimental work, generative chemistry can save both time and resources, making research more cost-effective.

5. Sustainability:
   - It enables the discovery of eco-friendly materials and green chemical processes, contributing to sustainability efforts.

Limitations of Generative Chemistry with RL:

1. Data Quality:
   - The quality and quantity of training data are critical. Biased or incomplete data can lead to biased models and unreliable predictions.

2. Chemical Knowledge:
   - AI algorithms may generate chemically valid but practically unusable molecules or materials, necessitating human expertise for validation.

3. Ethical Concerns:
   - The rapid generation of new chemical entities raises ethical concerns regarding safety, regulation, and the potential misuse of AI-generated molecules.

4. Interpretability:
   - RL models can be complex, making it challenging to interpret their decision-making processes, which is crucial for scientific understanding and regulatory approval.

5. Computational Resources:
   - Training RL models for generative chemistry can be computationally intensive, limiting accessibility to smaller research institutions and companies.

Conclusion:

Generative chemistry powered by reinforcement learning holds immense promise in revolutionizing drug discovery and materials science. Its ability to accelerate research, explore uncharted chemical space, and design customized materials has the potential to reshape industries and improve sustainability. However, it also faces challenges related to data quality, ethical concerns, and computational resources that must be addressed for its full potential to be realized. As this field continues to advance, it will likely play a pivotal role in shaping the future of chemistry and scientific innovation.

Tuesday, 6 December 2022

Key Research Articles


Billion-Dollar Biotransformations: On the Metabolism of Ozanimod | https://t.co/Q645d0Qcyn The fascinating metabolism of ozanimod, a likely megablockbuster drug for UC and MS, nearly derailed its approval. We explore the technical details here. Source: drughuntersite

Tuesday, 29 November 2022

Key Research Articles


RT @scipython3: Coming soon(-ish): Python for Chemists (CUP) https://t.co/ucF8Hlqep6

Friday, 25 November 2022

Key Research Articles


RT @ProfFeynman: 17 Equations that changed the world. 🧠 https://t.co/Ic9BWGcoKq

Key Research Articles


RT @pwk2013: #Atropisomerism is something that drug designers need to know about and here's an #OpenAccess review #isomerism #MedChem #SynChem #DrugDesign #OpenAccess https://t.co/DLljtFP6VK

Monday, 14 November 2022

Key Research Articles


RT @ErmanisKristaps: Only 2 weeks left to apply for a fully funded 42-month #PhDposition in my group! Focused on computational investigation of organic reactions and ML. https://t.co/OALpQ0eDVI Closes 30 November 2022. Please RT and get in touch if interested! #PhD #ChemJobs #compchem #chemtwitter

Friday, 11 November 2022

Key Research Articles


RT @ChemOrtuno: I have an open #compchem postdoc position to simulate ionic liquids with molecular dynamics. RT appreciated! Check link for details: https://t.co/9LWlgHJbIe

Wednesday, 9 November 2022

Key Research Articles


The Landscape of AI/ML in Drug Discovery | https://t.co/LnQJDGJRP1 The application of AI/ML methods to drug discovery has been an area of significant investment for at least 10 years now. This three-part Drug Hunter special on AI/ML in drug discovery summarizes the field. http https://t.co/8SZxU0SEtT

Thursday, 3 November 2022

Key Research Articles


What timing! Another great KRAS(G12C) example from Genentech just published today: https://t.co/Atn8hAR280 Source: drughuntersite

Monday, 24 October 2022

Key Research Articles


Thank You to Our Boston Event Sponsors | https://t.co/tgRTTVwCn9 Thanks to this week’s Boston event sponsors for helping make another great Drug Hunter mixer possible! We’ll be in the SF Bay Area, San Diego, Research Triangle, and the UK + EU soon - sign up to get notified https https://t.co/A22fhWG9nj

Tuesday, 18 October 2022

Key Research Articles


August 2022 #MoleculesOfTheMonth Runners-Up | https://t.co/fpNSM1oAbw You’ve seen Drug Hunter’s August Molecules of the Month; now read about five more that just missed out, featuring a drug for glioblastoma repurposed as a pan-apicomplexan antiparasitic agent, and more https:// https://t.co/LLgtPuJGlk

Wednesday, 12 October 2022

Key Research Articles


Drug Discovery Technology Review: Emerging Tools and Modalities in 2022Q2/Q3 | https://t.co/8fj0zL7jBb To keep you up to date on what’s happening in the biopharmaceutical industry, we’ve reviewed some of the most exciting updates from the past few months. #drughunter https://t https://t.co/ALs5xMPGxo

Friday, 7 October 2022

Key Research Articles


Billion-Dollar Molecules: Voxelotor, A $5.4 Billion Reversible Covalent Aldehyde | https://t.co/FEScFDVcyu Pfizer expands its presence in genetic diseases by acquiring voxelotor from Global Blood Therapeutics. Dive into the mechanism of action of the first-in-class drug and more https://t.co/vP7g4dTb5C

Tuesday, 4 October 2022

Key Research Articles


RT drughuntersite: ~~~~organic chemistry~~~~ https://t.co/xNgfygeVdw Source: drughuntersite https://t.co/4DEtooFcUB

Friday, 30 September 2022

Key Research Articles


August 2022 #MoleculesOfTheMonth | https://t.co/tIDCXd3z9i A covalent, proof-of-concept KRASG12R inhibitor, an oral dihydroorotate dehydrogenase inhibitor being developed for AML, and a first-in-class YAP-TEAD protein-protein are some examples of this month's MOTM. #drughunter https://t.co/xNaaDiYvjG

Tuesday, 27 September 2022

Key Research Articles


Drug Discovery Technology Review: Emerging Tools and Modalities in 2022Q2/Q3 | https://t.co/8fj0zKPIJD To keep you up to date on what’s happening in the biopharmaceutical industry, we’ve reviewed some of the most exciting updates from the past few months. #drughunter https://t https://t.co/ZDs7m0M0Em

Key Research Articles


Today (9/27) at 8:00AM PST (11:00AM EST): Recent Highlights in Drug Discovery: Q2/Q3 2022 We'll cover drug discovery highlights from Q2/3 of 2022, including scientific gems from recent drug approvals, Molecules of the Month, and more. Register: https://t.co/lToduYtXkF https:// https://t.co/nkXhQjME3k

Wednesday, 21 September 2022

Key Research Articles


RT @giribio: Well said "Don't get carried away by potency when selecting hits & leaving the kinase flatlands opens the door to exquisite" #drugdiscovery #compchem #medchem #cadd https://t.co/8ZTAKyJm5d

Tuesday, 20 September 2022

Key Research Articles


Do you want to learn basics of #compchem and #DFT in computational chemistry... Please go through the best practices... https://t.co/Uw7Dk3vjBY #abinitio #TuesdayMotivaton #learn #skill #quantumchemistry